Aluminum is the third most abundant element in the earth’s crust, yet very little makes its way into our bodies. A fact that is largely ignored by vaccine advocates is that dietary aluminum compounds dissociate in stomach acid and only between 0.01% and 1.0% is absorbed, typically 0.3%. In contrast, aluminum via vaccines is directly administered into our bodies and experimental evidence indicates that because of an adjuvant’s crystalline structure, it does not dissolve well. Note however, that not all vaccines contain aluminum.
First carefully read http://vaccinepapers.org/danger-aluminum-vaccines/ which gives an excellent explanation of what level of injected aluminum can be expected to cause neurological damage. Then read the following commentary to further help motivate the use of preterm babies in setting safety levels.
Where the Numbers Come From
A study by Bishop (1997) showed that preemies who received intravenous feeding solutions containing 19 micrograms/kg/day for 10 days suffered neurological damage. A two month old baby weighs about 5kg, so I arrived at 950 mcg by multiplying all the numbers together (19 * 10 * 5 = 950). Logically, receiving 950 mcg upfront (as with a routine pediatric visit) is more hazardous than spreading it out over 10 days, so the vaccine risks are understated.
The FDA safety limit is 5 mcg/kg/day and for a 5kg baby for 10 days, that translates to 250 mcg.
The amount of aluminum depends on the brand and the combination chosen. I computed the minimum as well as the maximum exposures by using aluminum content provided by Paul Offit, and found that one could minimize aluminum by choosing combination vaccines, like the DTaP/inactivated polio/Hib vaccine. While it is tempting to advise combination vaccines as the safest choice, there still isn’t a lot of data to see what happens when you combine a lot of viruses and bacteria together. F.ex., do they cross-contaminate leading to new DNA signatures that either enter host cells or cause cross-reactivity (wherein the immune system mistakes its own cells for the cross-contaminated proteins)?
A Comment on Why The Use of Premature Babies is Appropriate
Use of premature babies, who typically have impaired kidney function, is appropriate because
- It provides a conservative upper bound on toxic levels.
- Injected aluminum adjuvant, which has a nanoparticular crystalline structure, does not dissolve well.
First, there is the Flarend study  which shows that 96% of the aluminum hydroxide adjuvant was not excreted in adult rabbits with healthy kidneys even after 28 days since adjuvant administration. Another study showed that aluminum adjuvants did not cause an increase in urinary or serum levels of aluminum in 2-month old babies , which confirms the irrelevance of renal pathways, because if it is not in the blood or in the urine, then where is it? The reason is that aluminum nanoparticles are several orders of magnitude larger than what can be processed by the kidney  . These papers show that Aluminum adjuvants are around 200nm but the kidney can only clear particles < 10nm.
Second, we now know from several papers that human macrophages are recruited to the intra-muscular injection site and swallow aluminum particles, which is the mechanism that prevents dissolution and promotes dissemination to vital organs   . This also explains why Movsas, et al. did not see it in the blood, while at the same time observing signs of trauma .
Therefore kindey function is only relevant if the aluminum is dissolved into its ionic form, like normal salts, which is the form that you would get when you drink a cup of tea. Ionic, soluble aluminum coupled with poor kidney function can be likened to insoluble aluminum with normal kidney function. So, because aluminum adjuvants are special, the use of premature babies which have properties that mimic adjuvant exposure is entirely appropriate and understandable.
 Flarend: http://www.ncbi.nlm.nih.gov/pubmed/9302736
 Movsas: http://archpedi.jamanetwork.com/article.aspx?articleid=1712578
 Choi: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702539/
 Mold: http://www.nature.com/…/srep06287/full/srep06287.html
 Khan: http://www.ncbi.nlm.nih.gov/…/pdf/1741-7015-11-99.pdf
 Gherardi: http://www.ncbi.nlm.nih.gov/pubmed/11522584